CorMedix CRMD and Puma Biotechnology PBYI are small-cap biotech companies focused on the successful commercialization of their core products as they work to establish leadership within their ...

Small caps have started holding up better than many large-cap benchmarks, but this is not a blind rush into everything below ...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to breakthrough innovations and increased deals involving NASDAQ biotech stocks.

Both Iovance Biotherapeutics IOVA and Rigel Pharmaceuticals RIGL are small-cap companies focused on the successful commercialization of their marketed products. While Iovance is a cancer biotech ...

If you buy market folklore about January being an indicator for the rest of the year, the start of 2026 bodes well for small-cap stocks. The table is set for a "positive surprise" in small caps, ...

After several years of persistent headwinds, small-cap equities may finally be entering a more supportive phase. Lower interest rates matter disproportionately for small-cap businesses. Compared with ...

Small caps are set to open into a mixed but opportunity-rich session, with ASX futures edging higher despite a fragile global backdrop shaped by surging oil prices, falling bond yields and escalating ...